心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 ESC/EACTS指南：瓣膜性心脏病的管理

2021-08-28 欧洲心脏病学会 European Heart Journal

瓣膜性心脏病

2021年8月，由欧洲心脏病学会（ESC）和欧洲心胸外科协会（EACTS）制定的瓣膜性心脏病管理指南正式颁布，重点更新了主动脉瓣疾病、二尖瓣疾病以及三尖瓣疾病的诊疗策略选择。

中文标题：

2021 ESC/EACTS指南：瓣膜性心脏病的管理

英文标题：

2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Su

发布机构：

欧洲心脏病学会

发布日期：

2021-08-28

简要介绍：

2021年8月，由欧洲心脏病学会（ESC）和欧洲心胸外科协会（EACTS）制定的瓣膜性心脏病管理指南正式颁布，重点更新了主动脉瓣疾病、二尖瓣疾病以及三尖瓣疾病的诊疗策略选择。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021ESC／EACTS指南：瓣膜性心脏病的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4d0461c00218319b, title=2021 ESC/EACTS指南：瓣膜性心脏病的管理, enTitle=2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Su, guiderFrom=European Heart Journal, authorId=0, author=, summary=2021年8月，由欧洲心脏病学会（ESC）和欧洲心胸外科协会（EACTS）制定的瓣膜性心脏病管理指南正式颁布，重点更新了主动脉瓣疾病、二尖瓣疾病以及三尖瓣疾病的诊疗策略选择。, cover=https://img.medsci.cn/2021911/1631369224882_5579292.jpg, journalId=0, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会，会员超过70000人、提供更新指南、调查数据、组织学术会议，ESC年会是心血管领域最大的会议。下设5个分会（超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会）。提供指南较全面，按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Sat Aug 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，由欧洲心脏病学会（ESC）和欧洲心胸外科协会（EA</span><span style="color: #373737;"><span style="color: #02aba1;">CTS</span></span><span style="color: #373737;">）制定的瓣膜性心脏病管理指南正式颁布，重点更新了主动脉瓣疾病、二尖瓣疾病以及三尖瓣疾病的诊疗策略选择。</span></p>, tagList=[TagDto(tagId=57618, tagName=瓣膜性心脏病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=57618, guiderKeyword=瓣膜性心脏病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4557, appHits=313, showAppHits=0, pcHits=812, showPcHits=4244, likes=2, shares=23, comments=6, approvalStatus=1, publishedTime=Mon Sep 13 00:03:35 CST 2021, publishedTimeString=2021-08-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Sep 11 22:09:40 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Wed Jan 03 01:44:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021ESC／EACTS指南：瓣膜性心脏病的管理.pdf)])
2021ESC／EACTS指南：瓣膜性心脏病的管理.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1217376, encodeId=121d121e3769d, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a748129772, createdName=ms4000000747523652, createdTime=Fri May 06 15:53:42 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076069, encodeId=58a810e606927, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Thu Dec 02 06:56:59 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058560, encodeId=2c8c1058560b1, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Oct 08 11:00:25 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055936, encodeId=bd9a10559367f, content=XX, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Wed Sep 29 08:56:11 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055601, encodeId=193f105560170, content=实用 学到很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Sep 28 09:17:41 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2022-05-06 ms4000000747523652

    厉害

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1217376, encodeId=121d121e3769d, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a748129772, createdName=ms4000000747523652, createdTime=Fri May 06 15:53:42 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076069, encodeId=58a810e606927, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Thu Dec 02 06:56:59 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058560, encodeId=2c8c1058560b1, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Oct 08 11:00:25 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055936, encodeId=bd9a10559367f, content=XX, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Wed Sep 29 08:56:11 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055601, encodeId=193f105560170, content=实用 学到很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Sep 28 09:17:41 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-12-02 j3x

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1217376, encodeId=121d121e3769d, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a748129772, createdName=ms4000000747523652, createdTime=Fri May 06 15:53:42 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076069, encodeId=58a810e606927, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Thu Dec 02 06:56:59 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058560, encodeId=2c8c1058560b1, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Oct 08 11:00:25 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055936, encodeId=bd9a10559367f, content=XX, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Wed Sep 29 08:56:11 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055601, encodeId=193f105560170, content=实用 学到很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Sep 28 09:17:41 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-10-08 Doctoryangbai

    厉害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1217376, encodeId=121d121e3769d, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a748129772, createdName=ms4000000747523652, createdTime=Fri May 06 15:53:42 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076069, encodeId=58a810e606927, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Thu Dec 02 06:56:59 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058560, encodeId=2c8c1058560b1, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Oct 08 11:00:25 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055936, encodeId=bd9a10559367f, content=XX, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Wed Sep 29 08:56:11 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055601, encodeId=193f105560170, content=实用 学到很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Sep 28 09:17:41 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-29 H8888888

    XX

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1217376, encodeId=121d121e3769d, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a748129772, createdName=ms4000000747523652, createdTime=Fri May 06 15:53:42 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076069, encodeId=58a810e606927, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Thu Dec 02 06:56:59 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058560, encodeId=2c8c1058560b1, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Oct 08 11:00:25 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055936, encodeId=bd9a10559367f, content=XX, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Wed Sep 29 08:56:11 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055601, encodeId=193f105560170, content=实用 学到很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Sep 28 09:17:41 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-28 H8888888

    实用 学到很多

    0

拓展阅读

2023 HFA/ACVC/EAPCI 科学声明：急性心力衰竭和瓣膜性心脏病

欧洲心力衰竭协会(HFA,Heart Failure Association) · 2023-05-23